Compares treatment options for Bronchial Stents
Official title Surveillance Versus Bronchoscopy After Airway Stenting
ClinicalTrials.gov ID: NCT06935695
What this study is testing
- What it's testing
- Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.
You likely can't join if
- Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.
- Lobar or segmental stents alone
- Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy
- Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)
- Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.